Cargando…

Itaconic acid facilitates inflammation abatement and alleviates liver ischemia-reperfusion injury by inhibiting NF-κB/NLRP3/caspase-1 inflammasome axis

BACKGROUND: Ischemia-reperfusion injury (IRI) severely limits the efficacy and donor source of liver transplantation, and the crucial step in alleviating it is to control inflammation. Itaconic acid is a metabolite produced by intrinsic immune cells (especially macrophages) in the inflammatory state...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Ensi, Xing, Hao, Pei, Jiahao, Zhang, Quanbao, Li, Ruidong, Shen, Conghuan, Tao, Yifeng, Li, Jianhua, Ma, Zhenyu, Zhao, Jing, Wang, Zhengxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469154/ https://www.ncbi.nlm.nih.gov/pubmed/36111043 http://dx.doi.org/10.21037/atm-22-3388

Ejemplares similares

Development of a predictive nomogram for early recurrence of hepatocellular carcinoma in patients undergoing liver transplantation
por: Ma, Ensi, et al.
Publicado: (2021)

Effects of Tumor-Derived DNA on CXCL12-CXCR4 and CCL21-CCR7 Axes of Hepatocellular Carcinoma Cells and the Regulation of Sinomenine Hydrochloride
por: Shen, Conghuan, et al.
Publicado: (2022)

SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T
por: Tao, Yifeng, et al.
Publicado: (2020)

Cancer Cell-Derived Exosomes Promote HCC Tumorigenesis Through Hedgehog Pathway
por: Li, Li, et al.
Publicado: (2021)

Itaconate confers tolerance to late NLRP3 inflammasome activation
por: Bambouskova, Monika, et al.
Publicado: (2021)

The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
por: Hooftman, Alexander, et al.
Publicado: (2020)

Identification and validation of PCSK9 as a prognostic and immune-related influencing factor in tumorigenesis: a pan-cancer analysis
por: Sun, Chao, et al.
Publicado: (2023)

The m(6)A-related gene signature stratifies poor prognosis patients and characterizes immunosuppressive microenvironment in hepatocellular carcinoma
por: Ma, Ensi, et al.
Publicado: (2023)

Tetrandrine alleviates cerebral ischemia/reperfusion injury by suppressing NLRP3 inflammasome activation via Sirt-1
por: Wang, Jun, et al.
Publicado: (2020)

Comparison of Two Donor Liver Procurement Methods for Treatment of Pediatric Acute Liver Failure
por: Pei, Jiahao, et al.
Publicado: (2022)

Itaconate and fumarate derivatives inhibit priming and activation of the canonical NLRP3 inflammasome in macrophages
por: Hoyle, Christopher, et al.
Publicado: (2022)

Role of NLRP3 Inflammasome in Myocardial Ischemia-Reperfusion Injury and Ventricular Remodeling
por: Shen, Shichun, et al.
Publicado: (2022)

Itaconate Suppresses the Activation of Mitochondrial NLRP3 Inflammasome and Oxidative Stress in Allergic Airway Inflammation
por: Xie, Qiu-Meng, et al.
Publicado: (2023)

Itaconate Attenuates Neuroinflammation and Exerts Dopamine Neuroprotection in Parkinson’s Disease through Inhibiting NLRP3 Inflammasome
por: Sun, Guoqing, et al.
Publicado: (2022)

The Interplay between Autophagy and NLRP3 Inflammasome in Ischemia/Reperfusion Injury
por: Lv, Shuangyu, et al.
Publicado: (2021)

Lycopene alleviates hepatic ischemia reperfusion injury via the Nrf2/HO-1 pathway mediated NLRP3 inflammasome inhibition in Kupffer cells
por: Xue, Rong, et al.
Publicado: (2021)

Theacrine alleviates sepsis-induced acute kidney injury by repressing the activation of NLRP3/Caspase-1 inflammasome
por: Yang, Maoxian, et al.
Publicado: (2022)

Caspase-11 Interaction with NLRP3 Potentiates the Noncanonical Activation of the NLRP3 Inflammasome
por: Moretti, Julien, et al.
Publicado: (2022)

Corilagin alleviates intestinal ischemia/reperfusion-induced intestinal and lung injury in mice via inhibiting NLRP3 inflammasome activation and pyroptosis
por: Li, Wenlian, et al.
Publicado: (2022)

Microbiome-metabolomics analysis reveals abatement effects of itaconic acid on odorous compound production in Arbor Acre broilers
por: Zhu, Xin, et al.
Publicado: (2023)

Metabolite itaconate in host immunoregulation and defense
por: Yang, Wenchang, et al.
Publicado: (2023)

Inhibition of NLRP3 Inflammasome Ameliorates Cerebral Ischemia-Reperfusion Injury in Diabetic Mice
por: Hong, Pu, et al.
Publicado: (2018)

ADAM8 Activates NLRP3 Inflammasome to Promote Cerebral Ischemia-Reperfusion Injury
por: Lu, Hongwei, et al.
Publicado: (2021)

NLRP3 Inflammasome Activation: A Therapeutic Target for Cerebral Ischemia–Reperfusion Injury
por: Wang, Lixia, et al.
Publicado: (2022)

Selenium nanoparticles alleviate ischemia reperfusion injury-induced acute kidney injury by modulating GPx-1/NLRP3/Caspase-1 pathway
por: Wang, Shaobo, et al.
Publicado: (2022)

Parkin-Dependent Mitophagy Is Required for the Inhibition of ATF4 on NLRP3 Inflammasome Activation in Cerebral Ischemia-Reperfusion Injury in Rats
por: He, Qi, et al.
Publicado: (2019)

Costunolide covalently targets NACHT domain of NLRP3 to inhibit inflammasome activation and alleviate NLRP3-driven inflammatory diseases
por: Xu, Haowen, et al.
Publicado: (2023)

Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury through NLRP3 Inflammasome-Mediated Pyroptosis Inhibition via Activating Nrf2
por: Xiao, Lan, et al.
Publicado: (2021)

Qingkailing injection ameliorates cerebral ischemia-reperfusion injury and modulates the AMPK/NLRP3 Inflammasome Signalling pathway
por: Ma, Chongyang, et al.
Publicado: (2019)

Farrerol Alleviates Myocardial Ischemia/Reperfusion Injury by Targeting Macrophages and NLRP3
por: Zhou, Lin, et al.
Publicado: (2022)

Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia/reperfusion injury
por: Gong, Zhe, et al.
Publicado: (2018)

Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation
por: Huang, Yaru, et al.
Publicado: (2021)

The Role of NLRP3 Inflammasome Activation Pathway of Hepatic Macrophages in Liver Ischemia–Reperfusion Injury
por: Wu, Tong, et al.
Publicado: (2022)

Retracted: ADAM8 Activates NLRP3 Inflammasome to Promote Cerebral Ischemia-Reperfusion Injury
por: Healthcare Engineering, Journal of
Publicado: (2023)

Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome
por: Sun, Lingbin, et al.
Publicado: (2019)

Caspase-6 promotes activation of the caspase-11-NLRP3 inflammasome during gram-negative bacterial infections
por: Zheng, Min, et al.
Publicado: (2021)

Sulforaphane alleviates retinal ganglion cell death and inflammation by suppressing NLRP3 inflammasome activation in a rat model of retinal ischemia/reperfusion injury
por: Gong, Yuerong, et al.
Publicado: (2019)

Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury via Suppressing NLRP3 Inflammasome and Activating Autophagy
por: Ye, Jingxue, et al.
Publicado: (2020)

Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway
por: Zhang, Jing, et al.
Publicado: (2020)

ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury
por: Minutoli, Letteria, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7d35tb69jqpq8enesepd8t1k2a